Brief: Applied Molecular Transport Announces Publication Of Preclinical Data For Inflammatory Diseases In Journal Of Immunology
10/11/2020 13:15
Nov 10 (Reuters) - Applied Molecular Transport Inc.
AMTI.O :
* APPLIED MOLECULAR TRANSPORT ANNOUNCES PUBLICATION OF
PRECLINICAL
DATA DEMONSTRATING POTENTIAL OF NOVEL ORAL IL-10 BIOLOGIC
THERAPEUTIC (AMT-101) FOR INFLAMMATORY DISEASES IN JOURNAL OF
IMMUNOLOGY
Source text for Eikon: ID:nGNX5mnJbB
Further company coverage: AMTI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Applied Molecular Transport.
See all newsApplied Molecular Transport Inc. expected to post a loss of 50 cents a share - Earnings Preview
Brief: Applied Molecular Transport Inc. - On Oct 23 Got Written Notice Nasdaq Had Granted Co's Request For Continued Listing On Nasdaq
U.S. STOCKS ON THE MOVE-Boston Scientific, Rockwell Medical, Visa
U.S. STOCKS ON THE MOVE-Fox Corp, Cisco Systems, Darden Restaurants
Applied Molecular rises on merger deal with Cyclo Therapeutics